What drove the sharp decline in operating profit for Q1 2024?

The sharp decline in operating profit for Q1 2024 can be attributed to several key factors:

1. **Revenue Decline**: HP Inc. experienced a 4.4% year-over-year decline in net revenues, amounting to $13.2 billion, which fell short of the Zacks Consensus Estimate of $13.6 billion. This reduction in revenue, coupled with a 5% decrease in constant currency revenues, was primarily due to a volatile external environment impacting demand across the industry.
2. **Cost Management**: Despite the revenue decline, HP Inc. managed to improve operational efficiency and cost management, resulting in an 11% increase in the bottom line, with non-GAAP earnings of 81 cents per share. However, this was not enough to offset the revenue shortfall.
3. **Market Dynamics and Seasonality**: The Personal Systems (PS) segment, contributing 66.7% to net revenues, saw a 4% year-over-year revenue decrease, with commercial PS units sold declining 2% and consumer PS units down 1%. The printing business also faced challenges, with revenues dropping 5% year-over-year, mainly due to lower consumer and commercial printing revenues.
4. **Strategic Initiatives**: Integra LifeSciences faced a 0.3% year-over-year revenue drop, with total revenues missing the Zacks Consensus Estimate and experiencing a 1.2% organic revenue decline. The company's earnings per share also decreased by 5.3% year-over-year, missing the Zacks Consensus Estimate. This decline was attributed to the impact of certain non-recurring charges and the effects of the Boston recall and EU Medical Device Regulation charges.

In conclusion, the sharp decline in operating profit for Q1 2024 was primarily driven by revenue reductions, market challenges, and strategic initiatives, despite efforts to improve operational efficiency and cost management.

Latest Report Period
|code|stock code|Latest Report Period|market_code|
|---|---|---|---|
|NCSM|NCSM.O|2024Q4|186|
|RR|RR.O|2025Q1|186|
|AFCG|AFCG.O|2024Q4|185|
|MCB|MCB.N|2024Q4|169|
|EDU|EDU.N|2025Q2|169|
|PLUS|PLUS.O|2025Q3|185|
|AGNCO|AGNCO.O||185|
|GTX|GTX.O|2024Q4|185|
|NFE|NFE.O|2024Q4|185|
|LAB|LAB.O|2024Q4|185|